Matches in Nanopublications for { ?s ?p "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP622422.RAafWYYAnlAjKYn1ubrbxXAPRBrtByE1f6Uwx2X9q7kmQ130_assertion description "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622422.RAafWYYAnlAjKYn1ubrbxXAPRBrtByE1f6Uwx2X9q7kmQ130_provenance.
- NP1116286.RABELeoJkZWj7JRqYNQt8JPT-ZcHlMR3TJGc_S87AuEoI130_assertion description "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116286.RABELeoJkZWj7JRqYNQt8JPT-ZcHlMR3TJGc_S87AuEoI130_provenance.
- NP621010.RAhysOM1nbe2l9M1OdDHjUoT3csK0E1IcM8X1omFNC4Ts130_assertion description "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621010.RAhysOM1nbe2l9M1OdDHjUoT3csK0E1IcM8X1omFNC4Ts130_provenance.
- NP1116283.RAuNtDzD3zBxiaY8YSij2KA4KlJ7451LufWO3t1y3QlRQ130_assertion description "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116283.RAuNtDzD3zBxiaY8YSij2KA4KlJ7451LufWO3t1y3QlRQ130_provenance.
- NP1116284.RAmEW71PH5--ypwNfiLOOQByqH7cXbga5wJaD49lAquiY130_assertion description "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116284.RAmEW71PH5--ypwNfiLOOQByqH7cXbga5wJaD49lAquiY130_provenance.
- NP623735.RAJ_jOl33qIYv3W1_LW5MktZEJRPCQMETejTlxnsC3mSo130_assertion description "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623735.RAJ_jOl33qIYv3W1_LW5MktZEJRPCQMETejTlxnsC3mSo130_provenance.
- NP624872.RA1dJMg0OB0-J0CXKmRqfgIUhuCaWP3RYGS7wM6XUezUA130_assertion description "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624872.RA1dJMg0OB0-J0CXKmRqfgIUhuCaWP3RYGS7wM6XUezUA130_provenance.
- NP1116285.RA9JElnq1XDbgkUCQxjnCw1yj1jyf3UWknmkT3tIdSeDU130_assertion description "[Class I phosphoinositide 3-kinases (PI3K) have been extensively studied in different models these last years and several isoforms are now promising drug targets to treat cancer and immune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116285.RA9JElnq1XDbgkUCQxjnCw1yj1jyf3UWknmkT3tIdSeDU130_provenance.